Literature DB >> 12352616

Quantitative analysis of nociceptin in blood of patients with acute and chronic pain.

Myoung-Hwan Ko1, Yun-Hee Kim, Ran-Sook Woo, Kee-Won Kim.   

Abstract

This study aimed to define the change of serum level of nociceptin in pain patients. Seventy pain patients and 20 normal healthy subjects were enrolled. Patients were divided into three groups according to the duration of pain; (1) acute (within 4 weeks), (2) subacute (4 weeks to 6 months), and (3) chronic (> 6 months) state. Serum concentration of nociceptin was measured by radioimmunoassay. Serum nociceptin level was significantly higher in the patients with pain than in normal healthy subjects ( rho < 0.01). Furthermore, nociceptin level was significantly higher in the chronic pain group than acute group ( rho < 0.05). Serum nociceptin level has a relationship with the existence of pain and its duration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352616     DOI: 10.1097/00001756-200209160-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.

Authors:  Aldo Spadaro; Antonino Ajello; Carmelo Luigiano; Carmela Morace; Maria Letizia Resta; Grazia Berlinghieri; Salvatore Campo; Claudio Scisca; Angela Alibrandi; Graziella D'Arrigo; Nunziata Alessi; Oscar Ferrau; Maria Antonietta Freni
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons.

Authors:  Saifeldin Mahmoud; Wojciech Margas; Claudio Trapella; Girolamo Caló; Victor Ruiz-Velasco
Journal:  Mol Pharmacol       Date:  2010-02-16       Impact factor: 4.436

3.  Rising plasma nociceptin level during development of HCC: a case report.

Authors:  Andrea Horvath; Aniko Folhoffer; Peter Laszlo Lakatos; Judit Halosz; Gyorgy Illyes; Zsuzsa Schaff; Monika Beatrix Hantos; Kornelia Tekes; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

4.  Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.

Authors:  Ferenc Szalay; Monika B Hantos; Andrea Horvath; Peter L Lakatos; Aniko Folhoffer; Kinga Dunkel; Dalma Hegedus; Kornelia Tekes
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

5.  Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.

Authors:  Y Zhang; C D Simpson-Durand; K M Standifer
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

6.  Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD.

Authors:  Yong Zhang; Priyam R Gandhi; Kelly M Standifer
Journal:  Mol Pain       Date:  2012-10-20       Impact factor: 3.395

7.  Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures.

Authors:  Lan Zhang; Frank Stuber; Ulrike M Stamer
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

8.  Plasma concentrations of nociceptin/orphanin FQ: comparison of levels after general and neuraxial anesthesia for arthroscopic knee surgery.

Authors:  Heeseung Lee; Heehun Jeon
Journal:  Korean J Anesthesiol       Date:  2013-10-24

9.  Nociceptin is present in synovial fluid of patients undergoing total knee arthroplasty.

Authors:  Thomas A Verbeek; Nancy Ruth Jarbadan; Charles Davis; Julia Caldwell
Journal:  J Orthop Surg Res       Date:  2020-07-16       Impact factor: 2.359

10.  Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder.

Authors:  Yong Zhang; Kelly M Standifer
Journal:  Cell Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.